AQP4 and myelitis: When examining CSF white blood cell count collected within 30 days of myelitis onset, this was overall higher in “double-seronegative” patients compared with the AQP4-IgG seropositive NMOSD group (eTable 2; p = 0.34) but this was not statistically significant.